European application, no grantEurope
A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
EP 1154769 A1 · Applicant: BRISTOL-MYERS SQUIBB COMPANY
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 8, 2000 and never granted as a European patent. Had it been granted, its 20-year term would have ended February 8, 2020.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by August 8, 2025.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledFebruary 8, 2000
PublishedNovember 21, 2001
GrantedNever granted
Term endedFebruary 8, 2020
Application numberEP 00906015
Classification (CPC)A61P1/00 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.